Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis

被引：0

作者：

Elefsiniotis, Loannis S. ^{[1
]}

Dalekos, George N. ^{[2
,3
]}

Koskinas, John ^{[4
]}

Ioannidou, Panagiota ^{[6
]}

Cholongitas, Evangelos ^{[5
]}

Manolakopoulos, Spilios ^{[4
]}

Goulis, John ^{[5
]}

Vlachogiannakos, John ^{[6
]}

Deutsch, Melani ^{[4
]}

Triantos, Christos K. ^{[7
]}

Kapatais, Andreas ^{[8
]}

Sevastianos, Vassilios A. ^{[9
,10
]}

Schina, Maria J. ^{[9
,10
]}

Karatapanis, Stylianos ^{[11
]}

Ketikoglou, Loannis ^{[4
]}

Manesis, Emanuel K. ^{[4
]}

Papageorgiou, Maria-Vasiliki ^{[6
]}

Sinakos, Emanuel ^{[5
]}

Gatselis, Nikolaos K. ^{[2
,3
]}

Karagiannakis, Dimitrios ^{[6
]}

Tasovasili, Athanasia ^{[1
]}

Koukoufiki, Argyro ^{[5
]}

Voulgaris, Theodoros A. ^{[9
,10
]}

Tsolias, Chrysostomos ^{[7
]}

Akriviadis, Evangelos ^{[5
]}

Papatheodoridis, George V. ^{[6
]}

机构：

[1] Gen & Oncol Hosp Kifisia Agioi Anargyroi, Univ Dept Internal Med, Hepatogastroenterol Unit, Athens, Greece

[2] Univ Thessaly, Sch Med, Dept Med, Larisa, Greece

[3] Univ Thessaly, Sch Med, Res Lab Internal Med, Larisa, Greece

[4] Univ Athens, Hippokratio Gen Hosp Athens, Dept Internal Med 2, Athens, Greece

[5] Aristotle Univ Thessaloniki, Hippokratio Hosp, Med Dept 4, Thessaloniki, Greece

[6] Univ Athens, Laiko Gen Hosp, Dept Gastroenterol, Athens, Greece

[7] Univ Hosp Patras, Dept Gastroenterol, Patras, Greece

[8] Gen Hosp Western Attica, Athens, Greece

[9] Evangelismos Gen Hosp, Dept Internal Med 4, Athens, Greece

[10] Evangelismos Gen Hosp, Liver Outpatient Clin, Athens, Greece

[11] Gen Hosp Rhodes, Rhodes, Greece

来源：

HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1993

引用

页码：990A / 991A

页数：2

共 50 条

[1] All-Oral Treatment With Daclatasvir (DCV) Plus Sofosbuvir (SOF) Plus Ribavirin (RBV) for 12 or 16 Weeks in HCV Genotype (GT) 3-Infected Patients With Advanced Fibrosis or Cirrhosis: The ALLY-3+Phase 3 Study
Leroy, Vincent
Angus, Peter W.
Bronowicki, Jean-Pierre
Dore, Gregory
Hezode, Christophe
Pianko, Stephen
Pol, Stanislas
Stuart, Katherine A.
Tse, Edmund
McPhee, Fiona
Bhore, Rafia
Exposito, Maria Jesus Jimenez
Thompson, Alex J.
[J]. HEPATOLOGY, 2015, 62 (06) : 1380A - 1381A
[2] EFFICACY OF SOFOSBUVIR AND DACLATASVIR IN HIV/HCV CO-INFECTED PATIENTS WITH ADVANCED FIBROSIS
Antonini, T. M.
Bedoya, J. Ursic
Teicher, E.
Coilly, A.
de Martin, E.
Roque-Afonso, A. -M.
Quertainmont, Y.
Goujard, C.
Delfraissy, J. -F.
Vittecoq, D.
Samuel, D.
Duclos-Vallee, J. -C.
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S651 - S651
[3] PATIENT-REPORTED OUTCOMES (PROS) IN CHRONIC HEPATITIS C PATIENTS WITH CIRRHOSIS TREATED WITH SOFOSBUVIR (SOF) CONTAINING REGIMENS
Younossi, Z. M.
Stepanova, M.
Nader, F.
Nelson, D.
Lawitz, E.
Jacobson, I. M.
Gane, E.
Hunt, S. L.
[J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S449 - S450
[4] Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis
Ismail, Waleed A.
Yousef, Ayman E.
[J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1025 - 1029
[5] Improvement in liver disease parameters following treatment with daclatasvir plus sofosbuvir and ribavirin in patients with chronic HCV infection and advanced cirrhosis
Fontana, Robert J.
Poordad, Fred
Schiff, Eugene R.
Vierling, John M.
Landis, Charles S.
Bhore, Rafia
Yin, Philip
Noviello, Stephanie
Swenson, Eugene S.
[J]. HEPATOLOGY, 2015, 62 : 558A - 559A
[6] Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis
Hezode, Christophe
Dore, Gregory J.
Pianko, Stephen
Pol, Stanislas
Stuart, Katherine
Thompson, Alexander
Tse, Edmund
Bhore, Rafia
Jimenez-Exposito, Maria Jesus
[J]. GASTROENTEROLOGY, 2016, 150 (04) : S1096 - S1096
[7] DACLATASVIR PLUS SOFOSBUVIR PLUS RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT-EXPERIENCED PATIENTS WITH HCV GENOTYPE 3 INFECTION AND ADVANCED FIBROSIS OR CIRRHOSIS
Hezode, C.
Dore, G.
Pianko, S.
Pol, S.
Stuart, K.
Thompson, A.
Tse, E.
Bhore, R.
Jimenez-Exposito, M. J.
[J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S753 - S754
[8] Treatment Failure With Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Treatment Naive Patients With Chronic Hepatitis C Without Cirrhosis
Afzal, Muhammad
Tarar, Shahida Husain
Shah, Syed Muhammad Ali
Butt, Zamir
Ajmal, Muhammad
Younis, Irfan
Talat, Syed Usama
Akhtar, Hina
Ali, Javeria
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S560 - S561
[9] Combination Therapy of Daclatasvir (Daklinza®) with Sofosbuvir and Ribavirin in HCV-Patients with Genotype 3 and advanced Fibrosis or Cirrhosis
Viragh, Eszter
[J]. VISCERAL MEDICINE, 2016, 32 (01) : 64 - 64
[10] Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment
Moron Romero, Rocio
Diaz, Xando
del Carmen Gonzalez, Maria
Rodriguez, Alejandro
Casas, Inmaculada
Cabeza, Jose
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 331 - 331

← 1 2 3 4 5 →